On January 29, we gathered at the iconic Tour Eiffel for an exclusive evening with over 150 esteemed guests, including our distributors, partners and industry professionals. The event featured elegant cocktails, a company presentation and a gourmet dinner, creating the perfect setting to announce our latest innovation. This upcoming product, rich in formula and designed to elevate aesthetic treatments, was met with great enthusiasm from our guests. Key speakers, including CMed Aesthetics’ CEOs, Dr. Barbara Flora, Dr. Tamari Darjania, Dr. Samer Al Jalbout and Professor Firas Al-Niaimi, shared insights into the company’s vision and future advancements.
Following this special announcement, from January 30 to February 1, CMed Aesthetics took part in IMCAS 2025, one of the largest global congresses in aesthetic medicine. With more than 20,000 participants, the event was a valuable opportunity for insightful meetings, expert talks and industry interviews. Attendees engaged in an advanced training lab led by Professor Firas Al-Niaimi and a live demonstration by Dr. Samer Al Jalbout, showcasing innovative approaches and techniques. We also received remarkable feedback on CMed Aesthetics’ portfolio, including the recognition of BioRePeelCl3® as the first CE MDR-approved peeling.
It was a pleasure to connect with professionals from all over the world.
Follow us on social media to stay updated on our upcoming announcements!
